Align Technology: Only International Growth Can Save Them Now (Downgrade)

Robert J. Lake1.02K FollowersFollow5ShareSavePlay(25min)CommentsSummaryAlign Technology is downgraded to a hold as recent share gains have priced in much of the near-term upside.ALGN faces stagnating revenue, declining margins, and potential market share erosion in clear aligners, especially in North America.International markets, particularly Latin America and APAC, offer double-digit volume growth potential, but North American saturation limits overall growth.Strong balance sheet, robust free cash flow, and ongoing buybacks provide stability, but a lack of a clear path to double-digit growth tempers enthusiasm. Antonio_Diaz/iStock via Getty Images Based in Tempe, AZ, and founded in 1997, Align Technology, Inc. (ALGN) is a leading manufacturer of orthodontic treatments globally. They sell clear aligners under the Invisalign and Vivera brands as well as iTero scanners, alongsideThis article was written byRobert J. Lake1.02K FollowersFollowI have been investing in the stock market since I was 17 years old, and over the 25+ years since I have learned the joy of compounding, the value of dividend reinvesting, and the principle that patient investing through good times and bad brings the greatest rewards. I believe the key to creating wealth is the slow accumulation of high quality assets, and the key to enjoying the process of investing is to mix this steady approach with some high risk/high reward opportunities, underappreciated turnaround plays, and transformative technologies. I invest with integrity, only putting my money into companies and industries that aim to make the world a better place.I would consider myself an amateur investor, entirely self-taught with no formal education in investing or business, but smart at figuring out who is worth listening to. I read widely and embrace the notion that my own growth comes from learning from others. In my other life, I have been teaching at the college/university level for over 20 years. I have a PhD from Brunel University and am an accomplished academic writer and editor.Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article. Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.